Recalcitrant pustular psoriasis successfully treated with adalimumab

Area of Science:

• Dermatology
• Immunology
• Pharmacology

Background:

• Pustular psoriasis is a severe inflammatory skin condition.
• Treatment resistance is common in severe pediatric psoriasis cases.
• Multiple therapeutic options exist, but efficacy varies.

Observation:

• A 13-year-old female presented with severe pustular psoriasis.
• Previous treatments included methotrexate, acitretin, cyclosporin, and phototherapy.
• Biologic therapies, etanercept and infliximab, were also ineffective.

Findings:

• Adalimumab treatment resulted in an excellent clinical response.
• The patient achieved significant improvement in pustular psoriasis symptoms.
• This highlights adalimumab's potential in refractory cases.

Implications:

• Adalimumab may be a valuable therapeutic option for pediatric patients with severe, treatment-resistant pustular psoriasis.
• Further research into biologic sequencing and combination therapies is warranted.
• This case contributes to understanding treatment algorithms for severe psoriasis.